Nova Mentis Life Sciences Corp. (NMLSF)

[NetworkNewsWire]

LIBFF Subsidiary Inks Deal with Cannabis Compliance Inc.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) president and CEO Will Rascan this morning announced that the company’s wholly-owned subsidiary, North Road Ventures, has signed an agreement with Cannabis Compliance Inc. (“CCI”). Per the terms of the agreement, CCI will be responsible for assuring the Good Manufacturing Practice (“GMP”)-compliant processing and production of North Road’s products containing cannabis. GMP requirements ensure that the products manufactured are safe and of consistently high quality for their intended use. “This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the manufacture and sale of a wide range of medicinal-quality products for both human and veterinary use – not just cannabis and cannabis-containing finished products,” Robert Jackman, scientific project manager/fulfillment, stated in the news release.

To view the full press release, visit http://nnw.fm/QOyt3

About Liberty Leaf

Liberty Leaf Holdings Ltd. is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply-chain products within this dynamic and fast-growing sector. Liberty Leaf owns a 60% interest in Just Kush, along with 100% wholly-owned North Road Ventures, are both late-stage applicants under Health Canada’s ACMPR. For more information, visit the company’s website at www.LibLeaf.ca.